2-carboxyarabinitol 1-phosphate has been researched along with etoposide in 1 studies
| Studies (2-carboxyarabinitol 1-phosphate) | Trials (2-carboxyarabinitol 1-phosphate) | Recent Studies (post-2010) (2-carboxyarabinitol 1-phosphate) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
|---|---|---|---|---|---|
| 17 | 0 | 13 | 18,306 | 3,693 | 4,900 |
| Protein | Taxonomy | 2-carboxyarabinitol 1-phosphate (IC50) | etoposide (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
| Caspase-3 | Homo sapiens (human) | 1 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GW; Cho, MH; Churchwell, MI; Doerge, DR; Helferich, WG; Hergenrother, PJ; Hoagland, MS; Hwang, SK; Jin, H; Kwon, JT; Pearson, JM; Putt, KS; Sandhorst, JS | 1 |
1 other study(ies) available for 2-carboxyarabinitol 1-phosphate and etoposide
| Article | Year |
|---|---|
Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Hydrazones; In Vitro Techniques; Mice; Mice, Nude; Molecular Structure; Piperazines; Signal Transduction; Structure-Activity Relationship; Time Factors; Xenograft Model Antitumor Assays | 2006 |